4/8/2021China's 14th Five-Year Plan (2021-2025): Signposts for Doing Business ...

4/8/2021MNCs Rethink China Strategy as New Opportunities Emerge in Special Zon...

4/7/2021Shanghai Henlius Biotech Maps Out Its Biosimilars Future

4/7/2021Antengene Granted Chinese IND Approval for ATG-019 Clinical Trial

4/7/2021Chime Bio Builds Second Biomanufacturing Facility in Wuhan After Rais...

4/7/2021China Set to Initiate 5th Round of National Level Centralized VBP of D...

4/6/2021Crystec Launches New R&D Center in China

4/6/2021HitGen and BioAge Announce Research Progress in DNA-Encoded Library Ba...

4/6/2021NMPA Announces Package Insert Revision of Amikacin Injection and Cefur...

4/6/2021Snapshot of New Chinese biopharma IPOs 2019-2020

4/6/2021iX Biopharma Enters Cooperation Deal with China Resources Pharma Comme...

4/6/2021A Stronger Protection of Trade Secret in China

4/5/2021PharmaDJ's China Licensing Deals Tracker: Feb 2021

4/5/2021SMEI: Performance Review of Drug Products Included in the NRDL through...

4/2/2021CDE Issues the Technical Guidelines for Post-Marketing Pharmaceutical ...

4/2/2021Recent Executive Moves

4/2/2021Review of Drug Clinical Trials Applications and Registrations in China...

4/1/2021CStone Granted Chinese Approval of Precision Therapy AYVAKIT® (Avapr...

4/1/2021Lonza to Manufacture Gracell's FasTCAR-enabled CAR-T Cell Product Cand...

4/1/2021NHC: Health Awareness of Chinese Residents Rose to 23.15% in 2020

4/1/2021NHC Solicits Comments on Draft Long Term Drug Prescription Management ...

4/1/2021NH's DB6: Chinese Consumer Healthcare Market Review 2019-2020

4/1/2021NH's DB6: Top Ten Chinese OTC Brands in 2020

4/1/2021Patent Term Extension and Patent Linkage for Pharmaceutical Patents in...

3/31/2021China's Healthcare System: Addressing Capacity Shortfalls before and a...

3/31/2021PharmaDJ: New Regulations for Post-Market Drug Changes Remain Unclear ...

3/31/2021Everest Medicines Granted Clinical Trial Approval to Evaluate Trodelv...

3/31/2021Innovent's Parsaclisib Granted Breakthrough Therapy Designation in Ch...

3/31/2021Albumedix Enters Recombinant Human Albumin Supply Partnership with FU...

3/31/2021Henlius to File NDA of Anti-PD-1 mAb HLX10 for MSI-H Solid Tumours Aft...

Page:136/719 Total number of articles:21552: [First][<<] [134] [135] [136] [137] [138] [>>] [End]